Genetic Technologies Ltd representing 150 ordinary shares (GENE): Price and Financial Metrics


Genetic Technologies Ltd representing 150 ordinary shares (GENE)

Today's Latest Price: $2.41 USD

0.09 (3.88%)

Updated Jul 2 4:00pm

Add GENE to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

GENE Stock Summary

  • For GENE, its debt to operating expenses ratio is greater than that reported by merely 0.34% of US equities we're observing.
  • GENE's price/sales ratio is 26,106.87; that's higher than the P/S ratio of 99.96% of US stocks.
  • Revenue growth over the past 12 months for Genetic Technologies Ltd comes in at -99.21%, a number that bests only 0.54% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Genetic Technologies Ltd are IMMU, CYAD, ADVM, NK, and URGN.
  • GENE's SEC filings can be seen here. And to visit Genetic Technologies Ltd's official web site, go to www.gtglabs.com.
GENE Daily Price Range
GENE 52-Week Price Range

GENE Stock Price Chart Technical Analysis Charts


GENE Price/Volume Stats

Current price $2.41 52-week high $5.36
Prev. close $2.32 52-week low $1.41
Day low $2.18 Volume 1,129,383
Day high $2.45 Avg. volume 1,026,269
50-day MA $2.15 Dividend yield N/A
200-day MA $2.37 Market Cap 20.54M

GENE Latest News Stream


Event/TimeNews Detail
Loading, please wait...

GENE Latest Social Stream


Loading social stream, please wait...

View Full GENE Social Stream

Latest GENE News From Around the Web

Below are the latest news stories about Genetic Technologies Ltd that investors may wish to consider to help them evaluate GENE as an investment opportunity.

Genetic Technologies CEO to Participate in Investor Webinar and Q&A Session on June 24, 2020

MELBOURNE, Australia, June 23, 2020 -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”) is pleased to announce that its.

Yahoo | June 23, 2020

Genetic Technologies nabs new patent in assessing risk of breast cancer

The USPTO has issued Genetic Technologies (GENE), Patent No: US 10,683,549, Methods for assessing risk of developing breast cancer.The granted patent covers proprietary panels of single nucleotide polymorphisms (SNPs) and the combination of clinical and phenotypic risk models to create the most comprehensive risk assessment tool on the market: GeneType...

Seeking Alpha | June 18, 2020

US Patent Office Grants Key Risk Test Patent

Issuance of US Patent No: US 10,683,549, Methods for assessing risk of developing breast cancer.Filed provisional patent for its COVID-19 Severity Risk Test, 2020901739 –.

Yahoo | June 18, 2020

Insider Buying: The Genetic Technologies Limited (ASX:GTG) Independent Non-Executive Chairman Just Bought 24% More Shares

Potential Genetic Technologies Limited (ASX:GTG) shareholders may wish to note that the Independent Non-Executive...

Yahoo | June 4, 2020

Genetic Technologies Announces Closing of $8.0 Million Public Offering

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today announced the closing of its previously announced public offering of 3,500,000 American Depositary Shares (“ADSs”), each representing six hundred (600) of the Company’s ordinary shares, at an effective purchase price of $2.00 per ADS, and 500,000 pre-funded warrants, at an effective purchase price of $1.9999 per pre-funded warrant, for aggregate gross proceeds of approximately $8.0 million. The Company  intends to use the net proceeds from this offering to support the introduction and distribution of our new products in the United States, for general product research and development, including the development of polygenic risk tests, and reimburseme...

Yahoo | May 29, 2020

Read More 'GENE' Stories Here

GENE Price Returns

1-mo 19.90%
3-mo 57.52%
6-mo -46.56%
1-year -7.34%
3-year -29.12%
5-year -79.01%
YTD 21.10%
2019 -9.54%
2018 -52.59%
2017 7.41%
2016 -59.70%
2015 37.44%

Continue Researching GENE

Want to see what other sources are saying about Genetic Technologies Ltd's financials and stock price? Try the links below:

Genetic Technologies Ltd (GENE) Stock Price | Nasdaq
Genetic Technologies Ltd (GENE) Stock Quote, History and News - Yahoo Finance
Genetic Technologies Ltd (GENE) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8702 seconds.